Arbele
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
13555 SE 36th St Ste 100, Bellevue, Wash...Phone Number
(206) 451-0378Website
www.arbelebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Arbele
Arbele Limited is a biotech company specializing in the treatment of gastrointestinal cancers and solid tumors through its innovative Cadherin-17 biomarker technology. The company develops targeted therapies that enhance patient outcomes and quality of life, focusing on advanced treatments such as bispecific antibodies, antibody-drug conjugates, and advanced cell therapies. Arbele is committed to addressing significant unmet medical needs in cancer treatment, particularly for advanced solid tumors. Their mission is to provide cutting-edge solutions that bring hope and healing to those affected by cancer.Explore more
Arbele Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arbele your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Arbele has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Arbele recently announced quarterly report
Arbele, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Arbele launches new products
Check out if Arbele is spiking on competitors!
Funding: Get notified immidiatlly once Arbele has new funding data
Congratulate Masked Content for being promoted to Masked Content at Arbele
Click to see if Arbele had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Arbele as Masked Content
Find 3 more new buyers
Compare Similar Companies to Arbele
Compare insights from companies similar to Arbele, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Arbele is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Arbele is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Arbele.
Arbele Tech Stack
A closer look at the technologies used by Arbele
See more technologies
Most Recent Scoops
Hiring Plans
Arbele is hiring in Engineering & Technical for the first time in 12 months.
Hiring Plans
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Event
Arbele News & Media
Arbele Wins Top Prize at BCIC's 4th Annual Biomedical Pitch Competition
BOSTON, July 2, 2025 /PRNewswire/ -- Arbele Limited, a Hong Kong-based biotech company, was awarded first place at the 4th Biomedical Pitch Competition, hosted by the Boston Capital Investment Club (BCIC). Selected from over 170 companies across the U.S. and Asia, Arbele stood out for its...Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics
SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborations in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics...Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics
SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborations in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics of bispecific T-cell engagers (TCEs) and antibody-drug conjugates (ADCs). These partnerships, aimed at advancing the quantification and prognostic prediction of CDH17 expression in tumor tissue and the surroundiBioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials
MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arbele
Sign Up For FreeTo access detailed company insights
Arbele Limited is a biotech company specializing in the treatment of gastrointestinal cancers and solid tumors through its innovative Cadherin-17 biomarker technology. The company develops targeted therapies that enhance patient outcomes and quality of life, focusing on advanced treatments such as bispecific antibodies, antibody-drug conjugates, an... Read More
